Immunopharmacology and Immunotoxicology · 1994 · 25 citations · 34 references
Life SciencesImmunologyPharmacologyHypersensitivityImmunopathologyImmunotoxicologyCell-mediated ImmunityCellular Immune ResponsesHumoral Immune ResponsesImmunosuppressionMammalian ImmunologyRodent ImmunologyHemagglutination AssaysImmunosuppressive CompoundsMechanisms Of Immune-mediated Toxicity
In the present communication, we describe acrylamide (ACR) induced immunotoxicity and its modulation by an interferon inducer, the 6th mycelial fraction acetone (6-MFA) of Aspergillus ochraceus ATCC 28706. ACR administration to rats produced a significant decrease in the weight of spleen (p < 0.001), thymus (p < 0.001) and mesenteric lymph nodes (p < 0.05). A decrease in cellularity of spleen (p < 0.001), thymus (p < 0.001), bone marrow (p < 0.001) and circulating blood lymphocyte population (p < 0.001) was also recorded. ACR suppressed the humoral as well as cell mediated immunity as assessed by erythrocyte antibody complement (EAC)-rosettes (p < 0.001), hemagglutination titre (p < 0.001), PFC (p < 0.001) and the delayed type hypersensitivity response against sheep red blood cells (SRBC, p < 0.001). ACR treated immunosuppressed rats when treated with 6-MFA restored the circulating lymphocyte number to the normal level and a partial recovery in the weight of spleen and thymus. Potentiation of EAC-rosettes, hemagglutination titre, IgM-PFC and DTH response against SRBC was observed. It is concluded that 6-MFA ameliorate the ACR induced toxicity. This study may be of significance in prevention of ACR toxicity.
34
Peripheral Neuropathy in Rats Produced by Acrylamide
P. M. Fullerton, J. M. Barnes · Occupational and Environmental Medicine · 1966 · 244 citations · Full text
Medicine, Neurology, Neuroscience +17
D.D. McCollister, F. Oyen, V. K. Rowe · Toxicology and Applied Pharmacology · 1964 · 186 citations